THE EFFECT OF NOVEL COMPOUND MCC950 ON THE NLRP3 INFLAMMASOME IN THE RA JOINT

被引：2

作者：

McGarry, T. ^{[1
]}

Robertson, A. A. ^{[2
]}

Orr, C. ^{[1
]}

Coll, R. C. ^{[3
]}

Cooper, M. A. ^{[2
]}

O'Neill, L. A. ^{[3
]}

Veale, D. J. ^{[1
]}

Fearon, U. ^{[1
]}

机构：

[1] Univ Coll Dublin, Dublin Acad Med Ctr, Ctr Arthrit & Rheumat Dis, Dublin, Ireland

[2] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia

[3] Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷

关键词：

D O I：

10.1136/annrheumdis-2015-eular.3985

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0027

引用

页码：202 / 202

页数：1

共 50 条

[21] Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice [J].

Zhai, Yadong ;

Meng, Xiangbao ;

Ye, Tianyuan ;

Xie, Weijie ;

Sun, Guibo ;

Sun, Xiaobo .

MOLECULES, 2018, 23 (03)

[22] The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury [J].

Xu, Kai-Ying ;

Wu, Chuang-Yan ;

Tong, Song ;

Xiong, Peng ;

Wang, Si-Hua .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (04) :3031-3037

[23] MCC950 closes the active conformation of NLRP3 to an inactive state [J].

Ana Tapia-Abellán ;

Diego Angosto-Bazarra ;

Helios Martínez-Banaclocha ;

Carlos de Torre-Minguela ;

Jose P. Cerón-Carrasco ;

Horacio Pérez-Sánchez ;

Juan I. Arostegui ;

Pablo Pelegrin .

Nature Chemical Biology, 2019, 15 :560-564

[24] The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice [J].

Qu, Junwen ;

Yuan, Zhiqing ;

Wang, Guiyang ;

Wang, Xiaopeng ;

Li, Kewei .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 70 :147-155

[25] The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation [J].

Alan Cheuk Keong Yaw ;

Elaine Wan Ling Chan ;

Jeremy Kean Yi Yap ;

Chun Wai Mai .

Journal of Cancer Research and Clinical Oncology, 2020, 146 :2219-2229

[26] MCC950 closes the active conformation of NLRP3 to an inactive state [J].

Tapia-Abelian, Ana ;

Angosto-Bazarra, Diego ;

Martinez-Banaclocha, Helios ;

de Torre-Minguela, Carlos ;

Ceron-Carrasco, Jose P. ;

Perez-Sanchez, Horacio ;

Arostegui, Juan, I ;

Pelegrin, Pablo .

NATURE CHEMICAL BIOLOGY, 2019, 15 (06) :560-+

[27] The Small Molecule NLRP3 Inflammasome Inhibitor MCC950 Does Not Alter Wound Healing in Obese Mice [J].

Lee, James S. ;

Robertson, Avril A. B. ;

Cooper, Matthew A. ;

Khosrotehrani, Kiarash .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)

[28] NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia [J].

Hull, Claire ;

Dekeryte, Ruta ;

Buchanan, Heather ;

Kamli-Salino, Sarah ;

Robertson, Avril ;

Delibegovic, Mirela ;

Platt, Bettina .

NEUROPHARMACOLOGY, 2020, 180

[29] MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats [J].

Luo, Yujie ;

Lu, Jianan ;

Ruan, Wu ;

Guo, Xiaoming ;

Chen, Sheng .

BRAIN RESEARCH BULLETIN, 2019, 146 :320-326

[30] Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model [J].

Zhang, Weitian ;

Ba, Guangyi ;

Tang, Ru ;

Li, Mingxian ;

Lin, Hai .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 83

← 1 2 3 4 5 →